REFERENCES
- Balkwill F. (2009) Nature Reviews Cancer, 9, 361–371.
- Bennet B.L., Sasaki D.T., Murray B.W., O'Leary E.C., Sakata S.T., Xu W. et al.. (2001) PNAS, 98, 13681–13686.
- Dobreva Z.G. and Stanilova S.A. (2007) Immunopharmacol. Immunotoxicol., 29, 1–14.
- Dranoff G. (2004) Nature Reviews, 4, 11–22.
- Dunn G.P., Old L.J., Schreiber R.D. (2004) Immunity, 21, 137–148.
- Heriot A.G., Marriott J.B., Cookson S., Kumar D., Dalgleish A.G. (2000) Br. J. Cancer, 82, 1009–1012.
- Liu H., Sidiropoulos P., Song G., Pagliari L.J., Birrer M., Stein B., Anrather J., Pope R.M. (2000) J. Immunol., 164, 4277–4285.
- Mantovani A. and Sica A. (2010) Curr. Op. Immunol., 22, 231–237.
- Mytar B., Woloszyn M., Szatanek R., Bai- Krzyworzeka M., Siedlar M., Ruggiero I., Wieckiewicz J., Zembata M. (2003) J. Leukoc. Biol., 74, 1094–1101.
- Niciteas N.I., Tzanakis N., Gasouli M., Rallis G., Daniilidis K., Theodoropoulos G., Kostakis A., Peros G. (2005) World J. Gastroenterol., 11, 1639–1643.
- Popivanova B.K., Kitamura K., Wu Y., Kondo T., Kagaya T., Kaneko S., Oshima M., Fujii C., Mukaida N. (2008) J. Clin. Invest., 118, 560–570.
- Stanilova S.A., Dobreva Z.G., Slavov E.S., Miteva L.D. (2005) Int. Immunopharmacol., 5, 723–734.
- Trejo Y.G., Bordenave R.H., Beviacqua M., Zanoni L., Rumi L.S. (2001) J. Exp. Clin. Cancer Res., 20, 71–73.
- Waterston A. and Bower M. (2004) Cancer Therapy, 2, 131–148.
- Zhelev Z., Stanilova S., Carpenter B. (1994) Biochem. Biophys. Res. Commun., 202, 186–194.